JP2024527348A5 - - Google Patents

Info

Publication number
JP2024527348A5
JP2024527348A5 JP2024500201A JP2024500201A JP2024527348A5 JP 2024527348 A5 JP2024527348 A5 JP 2024527348A5 JP 2024500201 A JP2024500201 A JP 2024500201A JP 2024500201 A JP2024500201 A JP 2024500201A JP 2024527348 A5 JP2024527348 A5 JP 2024527348A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
particles
metered
composition according
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/036543 external-priority patent/WO2023283439A1/en
Publication of JP2024527348A publication Critical patent/JP2024527348A/ja
Publication of JP2024527348A5 publication Critical patent/JP2024527348A5/ja
Pending legal-status Critical Current

Links

JP2024500201A 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系 Pending JP2024527348A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163220362P 2021-07-09 2021-07-09
US63/220,362 2021-07-09
US202163282356P 2021-11-23 2021-11-23
US63/282,356 2021-11-23
PCT/US2022/036543 WO2023283439A1 (en) 2021-07-09 2022-07-08 Compositions, methods and systems for aerosol drug delivery

Publications (2)

Publication Number Publication Date
JP2024527348A JP2024527348A (ja) 2024-07-24
JP2024527348A5 true JP2024527348A5 (cg-RX-API-DMAC10.html) 2025-07-15

Family

ID=82748203

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2024500250A Pending JP2024525567A (ja) 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系
JP2024500201A Pending JP2024527348A (ja) 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系
JP2024500203A Pending JP2024525555A (ja) 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024500250A Pending JP2024525567A (ja) 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024500203A Pending JP2024525555A (ja) 2021-07-09 2022-07-08 エアロゾル薬物送達のための組成物、方法および系

Country Status (28)

Country Link
US (5) US20240358662A1 (cg-RX-API-DMAC10.html)
EP (6) EP4175620B1 (cg-RX-API-DMAC10.html)
JP (3) JP2024525567A (cg-RX-API-DMAC10.html)
KR (3) KR20240042437A (cg-RX-API-DMAC10.html)
AU (3) AU2022308837A1 (cg-RX-API-DMAC10.html)
CA (3) CA3226155A1 (cg-RX-API-DMAC10.html)
CL (3) CL2024000037A1 (cg-RX-API-DMAC10.html)
CO (3) CO2024000631A2 (cg-RX-API-DMAC10.html)
CR (3) CR20240064A (cg-RX-API-DMAC10.html)
DK (3) DK4197528T3 (cg-RX-API-DMAC10.html)
DO (3) DOP2024000004A (cg-RX-API-DMAC10.html)
EC (1) ECSP24011022A (cg-RX-API-DMAC10.html)
ES (3) ES2981514T3 (cg-RX-API-DMAC10.html)
FI (3) FI4175620T3 (cg-RX-API-DMAC10.html)
HR (3) HRP20240725T1 (cg-RX-API-DMAC10.html)
HU (3) HUE067281T2 (cg-RX-API-DMAC10.html)
IL (3) IL309907A (cg-RX-API-DMAC10.html)
LT (3) LT4175620T (cg-RX-API-DMAC10.html)
MA (3) MA60223B1 (cg-RX-API-DMAC10.html)
MX (3) MX2024000465A (cg-RX-API-DMAC10.html)
PE (3) PE20241067A1 (cg-RX-API-DMAC10.html)
PL (3) PL4175619T3 (cg-RX-API-DMAC10.html)
PT (3) PT4197528T (cg-RX-API-DMAC10.html)
RS (3) RS65597B1 (cg-RX-API-DMAC10.html)
SI (3) SI4197528T1 (cg-RX-API-DMAC10.html)
SM (3) SMT202400312T1 (cg-RX-API-DMAC10.html)
TW (3) TW202317081A (cg-RX-API-DMAC10.html)
WO (3) WO2023283441A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119836292A (zh) * 2022-04-28 2025-04-15 阿斯利康(瑞典)有限公司 用于治疗哮喘的沙丁胺醇和布地奈德的组合物和方法
CN116270464B (zh) * 2023-03-01 2025-09-30 深圳市贝美药业有限公司 一种克立硼罗气雾剂及其制备方法
FR3150798B1 (fr) 2023-07-07 2025-11-21 Aptar France Sas Dispositif de distribution de produit fluide
TW202600144A (zh) * 2024-02-23 2026-01-01 瑞典商阿斯特捷利康公司 Copd之三重組合療法
US12545493B2 (en) 2024-02-23 2026-02-10 Marcelo Lazaro Zelicovich Aerosol delivery system with enhanced air suspension
WO2026006658A1 (en) * 2024-06-27 2026-01-02 Lupin Inc. Stable pharmaceutical compositions for pressurized metered dose inhalers
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
GB202410910D0 (en) * 2024-07-25 2024-09-11 Bespak Europe Ltd Method of filling a pressurised dispensing container and filled pressurised dispensing container
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant
WO2026136361A2 (en) * 2024-12-17 2026-06-25 Kindeva Drug Delivery L.P. Metered dose inhalers and suspension compositions including polyethylene glycol
US12383516B1 (en) 2025-01-06 2025-08-12 Amphastar Pharmaceuticals, Inc. Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US37872A (en) 1863-03-10 Improved mast-hoop
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3994974A (en) 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
SE378109B (cg-RX-API-DMAC10.html) 1972-05-19 1975-08-18 Bofors Ab
US4187301A (en) 1978-04-05 1980-02-05 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
BE887518A (fr) 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
CY1359A (en) 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US5707634A (en) 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
AU706195B2 (en) 1995-04-14 1999-06-10 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US5833891A (en) 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
US5886200A (en) 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6010935A (en) 1997-08-21 2000-01-04 Micron Technology, Inc. Self aligned contacts
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
NZ500555A (en) 1999-08-02 2000-11-24 Hovione Int Ltd Process for the preparation of mometasone furoate
DE60025019T2 (de) 1999-10-29 2006-08-24 Nektar Therapeutics, San Carlos Trockenpulverzusammensetzungen mit verbesserter dispersivität
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US7279451B2 (en) * 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
PT2277972T (pt) 2002-10-25 2019-06-11 Honeywell Int Inc Composições contendo olefinas substituídas por flúor
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
WO2005000267A2 (en) 2003-05-28 2005-01-06 Nektar Therapeutics Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AU2006272438B2 (en) 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
CN100560598C (zh) 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 氟替卡松丙酸酯的合成方法
MX2009005359A (es) * 2006-11-20 2009-06-08 Cipla Ltd Dispositivo en aerosol.
PT2435025T (pt) 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SG181870A1 (en) * 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
AU2011368334A1 (en) * 2011-05-17 2013-11-21 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of two or more active agents
WO2013072938A2 (en) 2011-11-09 2013-05-23 Mylan Laboratories Ltd An improved process for the preparation of roflumilast
US20150136130A1 (en) * 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
WO2014060464A1 (en) 2012-10-17 2014-04-24 Interquim, S.A. Process for preparing roflumilast
CN110464724A (zh) * 2013-01-28 2019-11-19 理森制药股份公司 通过吸入罗氟司特n-氧化物治疗自身免疫、呼吸和/或炎性病症的方法
WO2014190204A1 (en) * 2013-05-22 2014-11-27 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of three or more active agents
KR102683072B1 (ko) 2017-10-09 2024-07-08 펄 테라퓨틱스 인코포레이티드 약물 전달 시스템

Similar Documents

Publication Publication Date Title
JP2024525555A5 (cg-RX-API-DMAC10.html)
JP2024525567A5 (cg-RX-API-DMAC10.html)
HRP20240753T1 (hr) Pripravci, postupci i sustavi za otpuštanje aerosolne djelatne tvari
JP6534397B2 (ja) グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物
CN102665678B (zh) 用于copd的联合治疗
RU2016107464A (ru) Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
CN102665680B (zh) 用于copd的气雾剂制剂
TW201609185A (zh) 溴化吡咯醣及福莫特羅組合之穩定加壓噴霧溶液組成物
RU98118908A (ru) Баллон для доставки фармацевтического состава, дозирующий ингалятор
CN102573791B (zh) 改进的制剂
CN109562061A (zh) 用于copd的组合疗法
ES2247959T1 (es) Formulacion medica en aerosol estabilizada en agua.
CN102695496B (zh) 用于copd的气雾剂制剂
EA007377B1 (ru) Композиции для ингаляции
EA036153B1 (ru) Фармацевтическая композиция для ингаляции, упакованная дозированная форма, капсула, способ лечения обструктивных заболеваний дыхательных путей и фармацевтический набор
ES2259915A1 (es) Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
US20040258624A1 (en) Combined doses
JP2024545816A5 (cg-RX-API-DMAC10.html)
CA2617717C (en) Use of tiotropium salts in the treatment of severe persistant asthma
US20060147387A1 (en) Process to minimize loss through adhesion to equipment surfaces
JP2011509936A (ja) 吸入薬物製品、システムおよび使用
Kim et al. Bronchodilators
BR102012027127A2 (pt) Composição contida em um inalador farmacêutico pressurizado com medidores de dosagem
TW202600124A (zh) 一種吸入性醫藥製劑、裝置及其用途
WO2023128916A1 (en) An apparatus with a grid (10) for the preparation of dry powder compositions for inhalation